What did @amyinhalf actually say?
Honestly? Almost nothing quotable. The transcript is a fragment of a song lyric: "I want you, I need you, oh God. Don't take this beautiful..." That's it. The video is tagged with #glp, #pcosweightloss, and #weightlosstransformation, and it appears to be a before-and-after transformation video set to music. There are no spoken medical claims here. The "content" is visual and emotional, not informational.
That matters for fact-checking purposes. We can't evaluate claims that weren't made. What we can do is assess the implicit message the video sends: that GLP-1 medication produced a dramatic physical transformation, the results are worth celebrating, and the feeling of having your body back is something worth fighting to keep.
Does the science back this up?
The general premise, that GLP-1 receptor agonists can produce significant weight loss in people with obesity or related conditions like PCOS, is well-supported. But "well-supported" is doing a lot of work here, and the details matter more than a before-and-after photo suggests.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found tirzepatide produced mean weight reductions of up to 22.5% over 72 weeks in adults with obesity. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg achieved roughly 15% mean body weight reduction. Those are averages across large populations. Individual results vary considerably, and the before-and-after format obscures that variance entirely. Some people lose very little. Some regain weight after stopping. The video shows one outcome.
On PCOS specifically, a 2023 review in Reproductive Sciences (Patel et al.) found GLP-1 agonists improved insulin sensitivity and androgen levels in women with PCOS beyond what weight loss alone explains. That's legitimately interesting, but it's mechanistic data, not a promise of transformation.
What did they get wrong (or right)?
Hard to penalize someone for a song lyric. @amyinhalf didn't make any false medical claims here, because she didn't make medical claims at all. The video is personal testimony, not advice. That's actually the right way to share a transformation story on social media, even if it's not always received that way by 1.9 million viewers.
What the format gets wrong, without the creator necessarily doing anything wrong, is the survivorship bias problem. Before-and-after content by definition only comes from people with results worth showing. You don't see the person who stayed on semaglutide for six months and lost four pounds. You don't see the person who stopped because of severe nausea, pancreatitis concerns, or cost. The hashtag ecosystem around GLP-1 on TikTok creates an implicit claim through selection: that this works, reliably, the way it worked for me. The data says something more complicated.
One thing the video does right: tagging #pcosweightloss alongside #glp suggests this creator understands her specific context. GLP-1 use in PCOS is an active and promising research area, not fringe usage.
What should you actually know?
If you watched this video and thought "I want that," here's what the science actually warrants saying. GLP-1 receptor agonists are among the most effective pharmacological tools we have for weight management right now. That's real. But response rates are heterogeneous, side effects are common (nausea affects up to 44% of semaglutide users in trials), and the weight loss is typically only sustained while on the medication.
A 2022 study in Diabetes, Obesity and Metabolism (Wilding et al.) showed that one year after stopping semaglutide, participants had regained two-thirds of their lost weight. Nobody's before-and-after video shows that part. Compounded versions of these medications are not equivalent to FDA-approved branded formulations and should not be treated as interchangeable. Anyone considering GLP-1 therapy should be evaluated by a licensed clinician who can assess cardiovascular history, thyroid risk, and whether the medication is appropriate for their specific situation.
The song lyric "don't take this beautiful" hits differently when you know that stopping the medication is, for many people, the next chapter.